Revium Rx
RVRC
$0.50
$0.098924.66%
| 09/30/2010 | 06/30/2010 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 158.16% | 1,502.27% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 158.16% | 1,502.27% | |||
| Operating Income | -158.16% | -1,502.27% | |||
| Income Before Tax | -158.16% | -1,502.27% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -158.16% | -1,502.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -158.16% | -1,502.27% | |||
| EBIT | -158.16% | -1,502.27% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -151.95% | -1,555.80% | |||
| Normalized Basic EPS | -151.96% | -1,556.23% | |||
| EPS Diluted | -151.95% | -1,555.80% | |||
| Normalized Diluted EPS | -151.96% | -1,556.23% | |||
| Average Basic Shares Outstanding | 2.51% | -3.15% | |||
| Average Diluted Shares Outstanding | 2.51% | -3.15% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
